[Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].

Objective: To retrospectively analyze the treatment outcomes and prognostic factors of nasal and nasopharyngeal peripheral T cell lymphomas (PTCL) patients.

Methods: One hundred and twelve patients with pathologically confirmed nasal and nasopharyngeal PTCL were included, among which 39 were CD56(+) NK/T cell lymphomas. The median pre-treatment disease course was 4 months.

[Clinical features and prognosis of nasal type NK/T cell lymphoma].

Objective: To investigate the clinical features, treatment modalities and the prognosis of nasal type NK/T cell lymphoma.

Methods: The data of 39 such patients treated from June 2000 to December 2003 were retrospectively reviewed. Twenty three patients were treated by combined chemoradiotherapy, basing on anthracycline-containing CHOP or similar regimens (median 5 cycles).